Predicted protein targets (top 9)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.43 |
| ▸ | ROCK2 | O75116 | 1/20 | 0.42 |
| ▸ | EGLN3 | Q9H6Z9 | 1/20 | 0.38 |
| ▸ | TBXAS1 | P24557 | 4/20 | 0.37 |
| ▸ | CYP19A1 | P11511 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.35 |
| ▸ | GAA | P10253 | 1/20 | 0.35 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23130227 | 0.84 | KMT2A (0.44) | KMT2A | |
| SCHEMBL17337060 | 0.81 | ROCK2 (0.41) | ALDH1A1ROCK2EGLN3TBXAS1MEN1 | |
| SCHEMBL17337609 | 0.81 | ROCK2 (0.41) | ALDH1A1ROCK2EGLN3TBXAS1MEN1 | |
| SCHEMBL23130215 | 0.77 | ALDH1A1 (0.43) | ALDH1A1ROCK2EGLN3TBXAS1CYP19A1 | |
| SCHEMBL23837552 | 0.75 | MTNR1A (0.36) | MEN1KMT2A | |
| SCHEMBL22474799 | 0.74 | ALDH1A1 (0.35) | ALDH1A1 | |
| SCHEMBL22474786 | 0.73 | HPGD (0.40) | ALDH1A1MEN1KMT2ASMN1; SMN2 | |
| SCHEMBL23837600 | 0.72 | TBXAS1 (0.39) | ALDH1A1ROCK2TBXAS1MEN1KMT2A | |
| SCHEMBL17347848 | 0.72 | KDM4E (0.43) | ALDH1A1ROCK2TBXAS1CYP19A1MEN1 | |
| SCHEMBL20807130 | 0.71 | PARP1 (0.40) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3882252-A1 | BETA-LACTAMASE INHIBITORS | Venatorx Pharmaceuticals, Inc. (US) | 2021-09-22 | — | — | EP | disclosed |